Over the past few years, several major advances have occurred in the understanding of how
the humoral and cellular immune system of humans recognizes and destroys transplant
cells, tissues and organs derived from animal sources. Consequently, armed with this new
knowledge, several laboratories have now developed novel immunoprotective technologies
that may allow xenotransplantation to be clinically feasible.